glp 1 palpitations GLP-1 receptor agonists and myocardial metabolism in atrial fibrillation If you take a GLP-1

8.3 Clinical decision matrix: stratification by metabolic phenotype and reproductive timeline 8.3.1 Dimensions Vertical Axis: High Risk: BMI 30 kg/m 2 comorbid with IR, MASLD, impaired glucose tolerance (IGT), or a significant family history of cardiovascular disease

Below, clinicians and researchers share insights on the neurological, behavioral, and emotional shifts they've observed and why many believe GLP-1s could play a meaningful role in addiction treatment and recovery support

GLP-1s are taking up significant fill-finish capacity in the pharmaceutical industry

In a study of 122,007 people, the least fit group had a death rate five times the fittest group, and being unfit carried a mortality risk equal to or worse than smoking, diabetes, or established heart disease (Mandsager, JAMA Network Open, 2018)